霍里霍兰投行
HLI
129.55
+1.04
+0.81%
霍里霍兰投行
US · HLI
#1588 按市值排名
上市于 2015
129.55
+1.04
+0.81%
实时 - 追踪5344个代码 - 心跳于4秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
涨跌不一/平稳
- 最近一期（2026/Q3）披露持股的机构数量减少了1家。
- 机构持股总比例基本持平。
机构持股
- 机构持股比例
- 80.35% +0.09pp
- 机构数量
- 591 -1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund67.77%
Hedge Fund6.12%
Individual/Insider4.90%
Public Company2.84%
Government Pension Fund1.09%
Private Company0.97%
Sovereign Wealth Fund0.94%
Family Office/Trust0.36%
Insurance Company0.19%
Other14.82%
主要股东 截至 2026-06-30
BlackRock
7.50% · 5.24M 股
Vanguard Capital Management, LLC
3.98% · 2.78M 股
Vanguard Portfolio Management, LLC
3.97% · 2.77M 股
Kayne Anderson Rudnick Investment Management, LLC
3.47% · 2.43M 股
EARNEST Partners, LLC
3.11% · 2.17M 股
RBC Global Asset Management Inc.
2.72% · 1.90M 股
State Street Global Advisors
2.50% · 1.75M 股
Eaton Vance Management
2.11% · 1.48M 股
Geode Capital Management, LLC
1.98% · 1.38M 股
Burgundy Asset Management Ltd.
1.84% · 1.28M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 22次买入 · 28次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Irwin Gold | Executive Chairperson | 1.52% |
| Scott Adelson | Co-President, Senior MD of Corporate Finance Group & Director | 1.29% |
| Scott Beiser | Chief Executive Officer | 1.13% |
| Paul Siegert | Financial Restructuring MD and Co-Head of Global Financial Restructuring Practice | 0.57% |
| J. Alley | MD & CFO | 0.11% |
| Todd Carter | Managing Director | 0.11% |
| Christopher Crain | MD, General Counsel & Secretary | 0.07% |
| Robert Schriesheim | Lead Independent Director | 0.04% |
| Jacqueline Kosecoff | Independent Director | 0.02% |
| Cyrus Walker | Independent Director | 0.01% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-30 | Thomas Reichert | Independent Director | Other Acquisition | +925 | -- |
| 2026-09-09 | Christopher Crain | MD, General Counsel & Secretary | Derivative Exercise and Sale | -1,000 | $140.15 |
| 2026-08-02 | J. Alley | MD & CFO | Open Market Acquisition | +4,020 | $124.52 |
| 2026-05-20 | Robert Schriesheim | Lead Independent Director | Other Acquisition | +1,129 | -- |
| 2026-05-20 | Scott Beiser | Chief Executive Officer | Derivative Exercise and Sale | -6,265 | $150.26 |
| 2026-05-20 | Paul Siegert | Financial Restructuring MD and Co-Head of Global Financial Restructuring Practice | Other Acquisition | +39,630 | -- |
| 2026-05-20 | Christopher Crain | MD, General Counsel & Secretary | Other Acquisition | +6,394 | -- |
| 2026-05-20 | J. Alley | MD & CFO | Other Acquisition | +7,100 | -- |
| 2026-05-20 | J. Alley | MD & CFO | Other Disposition | -7,100 | -- |
| 2026-05-20 | Scott Adelson | Co-President, Senior MD of Corporate Finance Group & Director | Other Acquisition | +34,548 | -- |
| 2026-05-20 | Paul Zuber | Independent Director | Other Acquisition | +797 | -- |
| 2026-05-20 | Cyrus Walker | Independent Director | Other Acquisition | +996 | -- |
| 2026-05-20 | Gillian Zucker | Independent Director | Other Acquisition | +996 | -- |
| 2026-05-20 | Ekpedeme Bassey | Independent Director | Other Acquisition | +797 | -- |
| 2026-05-20 | R. Mund | Independent Director | Other Acquisition | +476 | -- |
| 2026-05-18 | Christopher Crain | MD, General Counsel & Secretary | Sale to Issuer | -2,107 | $150.35 |
| 2026-05-14 | Irwin Gold | Executive Chairperson | Sale to Issuer | -4,619 | $150.35 |
| 2026-05-14 | Scott Beiser | Chief Executive Officer | Sale to Issuer | -6,497 | $150.35 |
| 2026-05-14 | Paul Siegert | Financial Restructuring MD and Co-Head of Global Financial Restructuring Practice | Sale to Issuer | -9,359 | $150.35 |
| 2026-05-14 | Todd Carter | Managing Director | Sale to Issuer | -13,707 | $150.35 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
霍里霍兰投行 讨论区 0 条评论